TECH.NASDAQBio-techne CORP

Form 4: BIO-TECHNE President Reports Stock Transaction

Sentiment:

Insider Transaction (Form 4)


William Geist, PRESIDENT, PROTEIN SCIENCES of BIO-TECHNE Corp, reported multiple transactions in common stock on August 15, 2026.

Summary

  • Option exercise/conversion: acquired 6,416 Common Stock on August 15, 2026; holds 26,919 after (Direct).
  • Tax/exercise-price withholding: disposed of 1,976 Common Stock at $72.40 ($143,062) on August 15, 2026; holds 24,943 after (Direct).
  • Option exercise/conversion: disposed of 567 Performance Restricted Stock Units on August 15, 2026; holds 8,507 after (Direct).
  • Disposition to the issuer: disposed of 8,507 Performance Restricted Stock Units on August 15, 2026 (Direct).
  • Disposition to the issuer: disposed of 22,898 Performance Stock Options (Right to Buy) on August 15, 2026; holds 1,526 after (Direct).
  • Option exercise/conversion: disposed of 2,623 Restricted Stock Units on August 15, 2026; holds 2,623 after (Direct).
  • Option exercise/conversion: disposed of 3,226 Restricted Stock Units on August 15, 2026; holds 6,452 after (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

William Geist — Officer (PRESIDENT, PROTEIN SCIENCES)

DateTransactionSecuritySharesPriceValueHeld After
2026-08-15Option exercise/conversionCommon Stock6,416——26,919
2026-08-15Tax/exercise-price withholdingCommon Stock1,976$72$143.1K24,943
2026-08-15Option exercise/conversionPerformance Restricted Stock Units567——8,507
2026-08-15Disposition to the issuerPerformance Restricted Stock Units8,507——0
2026-08-15Disposition to the issuerPerformance Stock Options (Right to Buy)22,898——1,526
2026-08-15Option exercise/conversionRestricted Stock Units2,623——2,623
2026-08-15Option exercise/conversionRestricted Stock Units3,226——6,452

Key Dates

DateDescription
2026-08-15Option exercise/conversion (6,416 shares)
2026-08-15Tax/exercise-price withholding (1,976 shares)
2026-08-15Option exercise/conversion (567 shares)
2026-08-15Disposition to the issuer (8,507 shares)
2026-08-15Disposition to the issuer (22,898 shares)
2026-08-15Option exercise/conversion (2,623 shares)
2026-08-15Option exercise/conversion (3,226 shares)

Keywords

insider transaction, Form 4, TECH, BIO-TECHNE Corp, neutral, William Geist

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.